MDxHealth
MDXH
12 hedge funds and large institutions have $37.6M invested in MDxHealth in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
99% more capital invested
Capital invested by funds: $18.9M → $37.6M (+$18.6M)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
32.68% more ownership
Funds ownership: 2.5% → 35.19% (+33%)
9% more funds holding
Funds holding: 11 → 12 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
MVM Partners
Boston,
Massachusetts
|
+$7.88M |
| 2 |
BL
Bleichroeder LP
New York
|
+$1.26M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$110K |
| 4 |
Renaissance Technologies
New York
|
+$54.8K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$32.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$783K |
| 2 |
Millennium Management
New York
|
-$38.3K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$33.7K |
MDXH Hedge Fund Activity: Q4 2023 in Review
12 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q4 2023, worth a combined $37.6M — up 99% from $18.9M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MDXH positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.
The largest buyer was MVM Partners, adding an estimated $7.88M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $783K sold.
- 12 institutional investors held MDxHealth (MDXH) as of Q4 2023, up from 11 in Q3 2023.
- Funds reported $37.6M of MDxHealth stock for Q4 2023, up 99% quarter-over-quarter.
- 3 funds opened new MDxHealth positions in Q4 2023 and 2 closed out, a net change of +1 holder.
- The largest MDxHealth buyer in Q4 2023 was MVM Partners, an estimated $7.88M added.
- The largest MDxHealth seller in Q4 2023 was Alyeska Investment Group, an estimated $783K sold.
Based on aggregated 13F filings for Q4 2023.